Ontology highlight
ABSTRACT:
SUBMITTER: Triplitt C
PROVIDER: S-EPMC4610726 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature
Triplitt Curtis C Cornell Susan S
Clinical medicine insights. Endocrinology and diabetes 20151018
Current guidelines for treatment of type 2 diabetes mellitus (T2DM) indicate a patient-centered approach that should go beyond glycemic control. Of the many antihyperglycemic agents available for treatment of T2DM, sodium-glucose cotransporter 2 (SGLT2) inhibitors offer the advantages of reduced glycated hemoglobin (A1C), body weight (BW), and systolic blood pressure (SBP) and are associated with a low risk of hypoglycemia when used either as monotherapy or with other agents not typically associ ...[more]